Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Impact of Frailty in Cardiogenic Shock: Nationwide Cohort Study

NCT07260084 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07260084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Impact of Frailty in Cardiogenic Shock: Nationwide Cohort Study
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
October 31, 2023
Enrollment
207,419 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age, cardiogenic shock, frailty